In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Avista Corporation’s current price ($36.85) is below the PERT-weighted fair value ($41.84), suggesting potential undervaluation with a 13.5% implied upside. Financial health scores indicate weakness, especially in growth (1.00/5). Monte Carlo analysis reveals high volatility and downside risk (28.1%), reflecting significant uncertainty despite a high expected value.